Aloe Blacc’s fame means nothing in biotech (and that’s the point) | TechCrunch
…Regulators require a commercialization plan, and philanthropy doesn’t move science through clinical trials or get you a license on university IP. Now, he’s bootstrapping a cancer drug platform targeting pancreatic…